Nobuhiro Hanai

11PUBLICATIONS
74CO-AUTHORS
Environmental epidemiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 27, 2026
Joint Effects of ALDH2 rs671 and Pathogenic Germline Variants in DNA Repair Genes on Risk of Aerodigestive and Gastrointestinal Cancers.

|Sep 08, 2026
Laryngeal NUT Carcinoma With BRD4::NUTM1 Fusion: A 4-Year Clinical Course Highlighting the Limitations of Current Multimodal Therapy.

|Jul 29, 2026
A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).

|Jun 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

|Jun 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

|Jun 22, 2026
Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

Pageof 2

Frequent Collaborators

6 joint publications

Naomi Kiyota

4 joint publications

Takeshi Kodaira

3 joint publications

Naoki Nishio

3 joint publications

Keita Sasaki